Search research articles
Contact Us
Filters
Showing results (921-930 of 1,095) with videos related to
Page
of 110
Sort By:
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]
|
July 29, 2022
Diagnosis and successful treatment of Brazillian porcupine poxvirus infection in a free-ranging hairy dwarf porcupine (Coendu spinosus)
Juliana Mariotti Guerra, Pedro Enrique Navas-Suárez, Eduardo Ferreira-Machado, et al.
Journal of Hepatology
|
February 11, 2018
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population
George V Papatheodoridis, Vana Sypsa, George Dalekos, et al.
The Lancet. Infectious Diseases
|
February 25, 2016
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
Michael Manns, Didier Samuel, Edward J Gane, et al.
The Journal of Infection
|
July 26, 2020
GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000-2016)
Antonio Aguilera, Rocío Trastoy, Francisco Rodríguez-Frias, et al.
Future Oncology (London, England)
|
June 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Alimentary Pharmacology & Therapeutics
|
September 27, 2024
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials
Maria Buti, Young-Suk Lim, Henry Lik Yuen Chan, et al.
JHEP Reports : Innovation in Hepatology
|
May 20, 2026
Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: insights from a multicenter European cohort
Sabela Lens, Habiba Kamal, Arno Furquim d'Almeida, et al.
Frontiers in Microbiology
|
April 20, 2026
Unveiling pathogens and contaminants: refining metagenomics for clinical diagnostics
Marta Ibañez-Lligoña, Sergi Colomer-Castell, Carolina Campos, et al.
ESMO Open
|
December 9, 2022
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program
S E Rebuzzi, A Signori, S Buti, et al.
Hepatology (Baltimore, Md.)
|
June 17, 2017
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
George V Papatheodoridis, Ramazan Idilman, George N Dalekos, et al.
Page
of 110
Search research articles
Search
Showing results (921-930 of 1,095) with videos related to
Sort By:
Page
of 110
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]
|
July 29, 2022
Diagnosis and successful treatment of Brazillian porcupine poxvirus infection in a free-ranging hairy dwarf porcupine (Coendu spinosus)
Juliana Mariotti Guerra, Pedro Enrique Navas-Suárez, Eduardo Ferreira-Machado, et al.
Journal of Hepatology
|
February 11, 2018
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population
George V Papatheodoridis, Vana Sypsa, George Dalekos, et al.
The Lancet. Infectious Diseases
|
February 25, 2016
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
Michael Manns, Didier Samuel, Edward J Gane, et al.
The Journal of Infection
|
July 26, 2020
GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000-2016)
Antonio Aguilera, Rocío Trastoy, Francisco Rodríguez-Frias, et al.
Future Oncology (London, England)
|
June 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Alimentary Pharmacology & Therapeutics
|
September 27, 2024
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials
Maria Buti, Young-Suk Lim, Henry Lik Yuen Chan, et al.
JHEP Reports : Innovation in Hepatology
|
May 20, 2026
Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: insights from a multicenter European cohort
Sabela Lens, Habiba Kamal, Arno Furquim d'Almeida, et al.
Frontiers in Microbiology
|
April 20, 2026
Unveiling pathogens and contaminants: refining metagenomics for clinical diagnostics
Marta Ibañez-Lligoña, Sergi Colomer-Castell, Carolina Campos, et al.
ESMO Open
|
December 9, 2022
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program
S E Rebuzzi, A Signori, S Buti, et al.
Hepatology (Baltimore, Md.)
|
June 17, 2017
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
George V Papatheodoridis, Ramazan Idilman, George N Dalekos, et al.
Page
of 110